Cazenove Capital Management’s Pfizer PFE Stock Holding History

Cazenove Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q2	$871K	Buy	+32,790	New	+$906K	0.7%	32

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Cazenove Capital Management's PFE Position: Q2 2013 in Review

Cazenove Capital Management opened a new position in Pfizer (PFE) in Q2 2013: 32,790 shares worth $871K. The stake represents 0.7% of the portfolio and ranks #32 among its holdings.

1,627 funds tracked by Wall St. Rank hold PFE as of Q2 2013.

Cazenove Capital Management held 32,790 shares of Pfizer worth $871K as of Q2 2013.
Pfizer was a new Cazenove Capital Management position in Q2 2013.
Pfizer made up 0.7% of Cazenove Capital Management's portfolio in Q2 2013, its #32 holding.
1,627 funds tracked by Wall St. Rank held Pfizer as of Q2 2013.

Based on Cazenove Capital Management's 13F filing for Q2 2013, filed 14 Aug 2013.